Immutrix Therapeutics

About:

Immutrix Therapeutics is a medical tech company that has developed a medical device for cleansing the blood.

Website: https://immutrix.com/

Description:

Immutrix Therapeutics s is a medical tech company that develops and markets blood cleansing treatment device. The company's product removes inflammatory mediators and toxins from blood using proprietary adsorbents and smart hollow fiber membranes. Immutrix products target and bind molecules (modifiers) of interest in a "dialysis-like" procedure to treat a broad range of medical conditions. The modifiers to be removed are those molecules which cause an undesired immune or pathological response, often referred to as mediators. The company was incorporated in 2009 and is based in Rapid City, South Dakota.

Total Funding Amount:

$3.13M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Rapid City, South Dakota, United States

Founded Date:

2009-01-01

Founders:

Carol Rae

Number of Employees:

11-50

Last Funding Date:

2017-11-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai